The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Remember Aber.-believe in the science!! Worry not that the SP is now at the same level as nearly 4 years ago despite all the
"good news"
Agree about Parker floundering about at the AGM. All we get is "it was the best option available" but no detailed explanation as to why.
Why should he care- on a cool Ā£58k for a three day week, doing what nobody knows, then if we go up the pictures he will resign and .... off to another Nice Little Earner.
Cynical- you bet your horses I am- fed up, like many others, to the back teeth with endless prevarication, jam tomorrow and appalling IR (email still not working-wonder why) been going on for well over a decade and even the most bullish contributors must be having more than a smidgen of doubt.
Hang on?? Jury still out.
*sp
We went through this before the AGM andā¦..nothing happened. The votes for on the resolutions were almost unanimous. Even if you get an EGM there is a very strong likelihood that any motion would be defeated.
Try complaining to the FCA instead about SP manipulation if it helps get the frustration out of your systems. Same result though! Nothing will change so wise until Bigeasy updates us on a shift of direction with his Intel.
Totally agree scientists in the lab and do we need someone more forward thinking at the helm is it time to start sharpening the pitchfork ?
Remember they work for us the share holders will wait to see what h he append to sp after 1801 news if no good maybe time to call an EGM
GLA
We have to assume that the BOD are working behind the scenes to remedy this ...
Hopefully they are fully focused on trying to replace the RF funding disaster with a more suitable solution ..
Excellent science but P.Poor managerial skills IMHO ... Parker looked out of depth at the AGM when questioned on funding options ..
Lets hope they are near to dropping some good news .... This BS can only go on for so long ... Job security should not be taken as a given if this carries on month on month !!!!!!
Time to deliver
How low can we go this is ridiculous luckily I donāt need to sell or would be well f.checked off
This is painful š©
Must be p@sing himself looking at the sp
GLA
Putting some weight on the SP this morning... News could be v close
Sareum have already used PYC's computational models. We are passed where it would even be relevant though. Unless we aquire the rights to a new compound.
A link below to the nature website( a login to the website may be needed to read the contents), regarding enlisting AI for drug discovery and development..etc. I am not sure if we! At Sarum are already into this game/field of technology ( a question to Dr Tim Mitchell and his colleagues)? My humble impression is that it is extremely vital that we do. If not, what is the blocker? Funding and finance, I guess?
Many thanks.
https://www.nature.com/articles/d41586-023-02896-9
Yes, by way of a change we are Lazarus, only 5% down so far!
What's the consensus, do we expect the share price to soften further on the drawdown of further funding next month? I'm anticipating it will to some extent by what's happened to date.........
You normally only post preceding a drop or during a drop Surfie. Are we dropping today?
At the moment this turd needs a good polish. Down again yesterday, down over 10% over the past 5 days ans over 30% the past month. Let's see what today brings.
HE1 which scaled heights just like SAR in 2021 then collapsed dramatically has suddenly exploded upwards 10 fold in last week or so. Same could happen with SAR.
Hi Andy, I'm a qualified turd polisher. One of the select few in this country. As you may know, there is no point in polishing a fresh turd, as it has that natural freshly made sheen. To deal with it then would ruin its freshly made appeal. No, you have to wait a little while for it to cool down and firm up, even grey a bit from its rich brown colour. Then that is when a turd polished makes his move. A skillfull turd polished never gets his wind up,he has no need of gloves as its a definite hands on technique. The secret is to massage it to bring the beautiful brown coloured gloss back to the surface. This is is not a skill that is easily mastered but by practising it on any firm turd success can usually be mastered after making a little effort. Plenty of videos out there on YouTube for those that want to watch.
Potnak, re Del Boy, fair enough. Please accept my apols. I think we are, perhaps, closer to a breakthrough than many here think, and therefore any negotiations would be on a much firmer footing once news is released. But it is just my opinion, appreciate others have different views for a variety of reasons.
Hi Andy, I'm a qualified turd polisher. One of the select few in this country. As you may know, there is no point in polishing a fresh turd, as it has that natural freshly made sheen. To deal with it then would ruin its freshly made appeal. No, you have to wait a little while for it to cool down and firm up, even grey a bit from its rich brown colour. Then that is when a turd polished makes his move. A skillfull turd polished has no need of gloves as its a definite hands on technique. Remassa
...82.54% down now!? (Oh Joy!)
Well the third and fourth drawdown become available on the 4th February. Ā£300000 for the third and Ā£1400000 for the fourth. Yes, another Ā£1.7 million in February. They took the second in November and unless there's a miracle, they will take the third and fourth too.
Good to see you posting stranger, albeit, can understand you reclusive stance, getting that way for me to, that said hope you and family well.
As usual, a measured posting from your goodself.
@ Lazurus2, likewise a sound post.
@ Potnak, personally I'd rather John Reader was at any negotiating table when discussing our compounds!!
GLA
Https://endpts.com/bristol-myers-opdivo-fails-part-two-of-post-kidney-cancer-surgery-test-as-competitor-merck-touts-new-survival-data/
Maybe BMS s failure could be a significant opportunity for Sar s 1802 to be resurrected and fully developed in collaboration in the joint targeting of Kidney cancer one of Sar s previously stated targets for SDC 1802 .An option to be considered and get this molecule up and running
GLA
I sort of agree, Andy but that scenario only works if we are following all the way to market. There is plenty of time to do a deal that will add significant value way before we get to find if it is the drug we've been waiting for. I certainly down want to go past phase 2 and will look for exits all the way yo that point.
Interestingly we shouldn't be drawing down further on the RF facility during Q1 or until we have results from the P1a /
"The First Deposit, Further Deposits and anticipated tax credits during the remainder of 2023 are expected to be sufficient to enable the Company to complete the Phase 1a part of the SDC-1801 clinical study, and to provide funding through to Q1 2024.
In the event that the Company is unable to draw down the majority of the additional Ā£2.4 million potentially available under the Facility as and when expected, the Company will require alternative funding to complete the Phase 1b clinical developments activities being progressed and to provide working capital."